RNSG 1301 Exam 1 Test Questions and Answers Rated A
drugs sold by their generic name; not brand (or trade)
Generic drugs
name products
name given to a drug by the pharmaceutical company that
Brand name
developed it; also called a trade name
Once the patent on a brand name runs out manufactures
develop genetic drugs which are intended work on in
the same way (quality, dosage, strength, and route of
administration).
Genetic drugs vs Brand name
The bioavailability of the generic drugs may ditter from the
brand name. This is why providers might specify "dispense
as written" so brand name product may use especially in
drugs that have narrow safety margins.
High abuse potential and no accepted medical use (hero-
Control substance - (C-I) Schedule I
in, marijuana, LSD)
High abuse potential with severe dependence liability
(narcotics, amphetamines, and barbiturates)
Example: Cocaine, methamphetamines, methadone, Di-
Control substance - (C-II) Schedule II
laudid, Demerol, Oxycodone, Fentanyl, Morphine, Adder-
all, Ritalin, Dexedrine.
Written prescription only, no refills
Less abuse potential than schedule II drugs and moderate
dependence liability (nonbarbiturate sedatives, nonam-
phetamine stimulants, limited amounts of certain nar-
cotics)
Control substance - (C-III) Schedule III
< 15 mg hydrocodone per dosage unit (Vicodin) ; < 90
mg of codeine p3er dosage unit (Tylenol w/ codeine);
ketamine; anabolic steroids; testosterone
1/9
, RNSG 1301 Exam 1 Test Questions and Answers Rated A
Written/Oral Rx that expired w/n 6mos. No more than 5
refills.
Less abuse potential than schedule III and limited depen-
dence liability (some sedatives, antianxiety agents, and
nonnarcotic analgesics)
Control substance - (C-IV) Schedule IV
Examples: Xanax, Soma, Valium, Ativan, Talwin, Ambien
Written/Oral Rx that expires w/n 6 mons. No more than 5
refills.
Limited abuse potential
Cough suppressants < 200 mg codeine/100 mL (Robi-
Control substance - (C-V) Schedule V tussin AC), Lomotil, Motofen, Lyrica, Parepectolin
Written Rx or OTC; must be 18 yo, ID must be showed, and
dispensing must be recorded
Control over the coding of drugs and the enforcement of
The Controlled Substances Act of 1970 these codes to the FDA and the Drug Enforcement Agency
(DEA), a part of the U.S. Department of Justice.
Adequate studies in pregnant women have not demon-
Pregnancy category A strated a risk to the fetus in the first trimester of pregnancy,
and there is no evidence of risk in later trimesters.
Animal studies have not demonstrated a risk to the fetus
Pregnancy category B
but there are no adequate studies in pregnant women.
Animal studies have shown an adverse ettect on the fetus
but there are no adequate studies in humans; the benefits
Pregnancy category C from the use of the drug in pregnant women may be ac-
ceptable despite its potential risks, or there are no animal
reproduction studies and no adequate studies in humans.
2/9
drugs sold by their generic name; not brand (or trade)
Generic drugs
name products
name given to a drug by the pharmaceutical company that
Brand name
developed it; also called a trade name
Once the patent on a brand name runs out manufactures
develop genetic drugs which are intended work on in
the same way (quality, dosage, strength, and route of
administration).
Genetic drugs vs Brand name
The bioavailability of the generic drugs may ditter from the
brand name. This is why providers might specify "dispense
as written" so brand name product may use especially in
drugs that have narrow safety margins.
High abuse potential and no accepted medical use (hero-
Control substance - (C-I) Schedule I
in, marijuana, LSD)
High abuse potential with severe dependence liability
(narcotics, amphetamines, and barbiturates)
Example: Cocaine, methamphetamines, methadone, Di-
Control substance - (C-II) Schedule II
laudid, Demerol, Oxycodone, Fentanyl, Morphine, Adder-
all, Ritalin, Dexedrine.
Written prescription only, no refills
Less abuse potential than schedule II drugs and moderate
dependence liability (nonbarbiturate sedatives, nonam-
phetamine stimulants, limited amounts of certain nar-
cotics)
Control substance - (C-III) Schedule III
< 15 mg hydrocodone per dosage unit (Vicodin) ; < 90
mg of codeine p3er dosage unit (Tylenol w/ codeine);
ketamine; anabolic steroids; testosterone
1/9
, RNSG 1301 Exam 1 Test Questions and Answers Rated A
Written/Oral Rx that expired w/n 6mos. No more than 5
refills.
Less abuse potential than schedule III and limited depen-
dence liability (some sedatives, antianxiety agents, and
nonnarcotic analgesics)
Control substance - (C-IV) Schedule IV
Examples: Xanax, Soma, Valium, Ativan, Talwin, Ambien
Written/Oral Rx that expires w/n 6 mons. No more than 5
refills.
Limited abuse potential
Cough suppressants < 200 mg codeine/100 mL (Robi-
Control substance - (C-V) Schedule V tussin AC), Lomotil, Motofen, Lyrica, Parepectolin
Written Rx or OTC; must be 18 yo, ID must be showed, and
dispensing must be recorded
Control over the coding of drugs and the enforcement of
The Controlled Substances Act of 1970 these codes to the FDA and the Drug Enforcement Agency
(DEA), a part of the U.S. Department of Justice.
Adequate studies in pregnant women have not demon-
Pregnancy category A strated a risk to the fetus in the first trimester of pregnancy,
and there is no evidence of risk in later trimesters.
Animal studies have not demonstrated a risk to the fetus
Pregnancy category B
but there are no adequate studies in pregnant women.
Animal studies have shown an adverse ettect on the fetus
but there are no adequate studies in humans; the benefits
Pregnancy category C from the use of the drug in pregnant women may be ac-
ceptable despite its potential risks, or there are no animal
reproduction studies and no adequate studies in humans.
2/9
